Efficacy, public health impact and optimal use of the Takeda dengue vaccine

Bethan Cracknell Daniels, Neil Ferguson, Ilaria Dorigatti
doi: https://doi.org/10.1101/2024.08.10.24311393

Article Information

doi 
https://doi.org/10.1101/2024.08.10.24311393
History 
  • August 11, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Bethan Cracknell Daniels1,
  2. Neil Ferguson1,* and
  3. Ilaria Dorigatti1,*
  1. 1MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
  1. ↵*Corresponding authors email: i.dorigatti{at}imperial.ac.uk
Back to top
Posted August 11, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy, public health impact and optimal use of the Takeda dengue vaccine
Bethan Cracknell Daniels, Neil Ferguson, Ilaria Dorigatti
medRxiv 2024.08.10.24311393; doi: https://doi.org/10.1101/2024.08.10.24311393
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area